With a $125 million series B financing round, Diagonal Therapeutics has made a vertical move to advance its first-in-class rare disease drug DIAG723. The Massachusetts-based biotech, which develops ...

Biotechnology startup Diagonal Therapeutics has added $125 million to its coffers, the company said Thursday, in a Series B round that will propel its first drug prospect into the clinic this year.

Driving around areas of New England, particularly north-central Vermont, you might notice some unique architectural choices. You first might be struck by the beauty of older buildings or the ...

Genomic best linear unbiased prediction (GBLUP) is a key method in genomic prediction, relying on the construction of a genomic relationship matrix (G-matrix). Although various methods for G-matrix ...

The Matrix hit theaters in 1999 and dazzled audiences with a leather-clad and gravity-defying Keanu Reeves, as he, along with Carrie-Anne Moss and Laurence Fishburne, fought against artificial agents ...

Nick Battista walks through real-time trades with insights into strategy selection and management throughout the duration of the trade. See the open orders, management and adjustments mechanics, all ...

Indigenous nations such as Ojibwe, Odawa, Potawatomi, Miami, and others – as well as their roads – were here long before Chicago was incorporated.

In a drug discovery career spanning more than two decades, Alex Lugovskoy has seen a lot of antibodies come and go. The vast majority of them work by inhibiting a cellular function. Lugovskoy, now the ...

Warner Bros. announced Wednesday the fifth installment of its flagship cyberpunk movie franchise “The Matrix” is in development, years after the last movie in the franchise, “The Matrix Resurrections” ...